Mrs
Dr
Miss
Ms
Prof
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/1945445
NoToPharm s.r.l. - Product Pipeline Analysis
Description:
NoToPharm s.r.l. - Product Pipeline Analysis
Summary
NoToPharm s.r.l. (NotoPharm) is engaged in research and development (R&D) in the field of autoimmunity, with particular interest in the discovery and characterization of new biomarkers for the differential diagnosis of autoimmune diseases. The company develops diagnostic kits used in autoimmunity treatments. It also develops a diagnostic kit with a new molecular marker (IFI16) used in the diagnosis of systemic sclerosis, systemic lupus erythematosus, and Sjogren syndrome with applications in other autoimmune diseases such as mixed connectivitis, polymyositis, and dermatomyositis. NoToPharm is an academic spin-off from the University of Piemonte Orientale.
This report is a source for data, analysis and actionable intelligence on the NoToPharm s.r.l. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Summary
NoToPharm s.r.l. (NotoPharm) is engaged in research and development (R&D) in the field of autoimmunity, with particular interest in the discovery and characterization of new biomarkers for the differential diagnosis of autoimmune diseases. The company develops diagnostic kits used in autoimmunity treatments. It also develops a diagnostic kit with a new molecular marker (IFI16) used in the diagnosis of systemic sclerosis, systemic lupus erythematosus, and Sjogren syndrome with applications in other autoimmune diseases such as mixed connectivitis, polymyositis, and dermatomyositis. NoToPharm is an academic spin-off from the University of Piemonte Orientale.
This report is a source for data, analysis and actionable intelligence on the NoToPharm s.r.l. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Contents:
List of Tables
List of Figures
Key Facts
NoToPharm s.r.l. - Major Products and Services
NoToPharm s.r.l. Pipeline Products by Equipment Type
NoToPharm s.r.l. Pipeline Products by Development Stage
NoToPharm s.r.l. Pipeline Products by Therapy Area
Diagnostic Assay - Dermatomyositis
Product Status
Product Description
Diagnostic Assay - Mixed Connectivitis
Product Status
Product Description
Diagnostic Assay - Polimyositis
Product Status
Product Description
Diagnostic Assay - Sjogren Syndrome
Product Status
Product Description
Diagnostic Assay - Systemic Lupus Erythematosus
Product Status
Product Description
Diagnostic Assay - Systemic Sclerosis
Product Status
Product Description
NoToPharm s.r.l. - Key Competitors
NoToPharm s.r.l. - Key Employees
NoToPharm s.r.l. - Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
NoToPharm s.r.l., Key Facts
NoToPharm s.r.l. Key Pipeline Products by Equipment Type
NoToPharm s.r.l. Key Pipeline Products by Therapy Area
NoToPharm s.r.l. Key Pipeline Products by Development Stage
NoToPharm s.r.l., Key Facts
NoToPharm s.r.l., Major Products and Services
NoToPharm s.r.l. Number of Pipeline Products by Equipment Type
NoToPharm s.r.l. Pipeline Products by Equipment Type
NoToPharm s.r.l. Number of Pipeline Products by Development Stage
NoToPharm s.r.l. Pipeline Products by Development Stage
NoToPharm s.r.l. Number of Pipeline Products by Therapy Area
NoToPharm s.r.l. Pipeline Products by Therapy Area
Diagnostic Assay - Dermatomyositis - Product Status
Diagnostic Assay - Dermatomyositis - Product Description
Diagnostic Assay - Mixed Connectivitis - Product Status
Diagnostic Assay - Mixed Connectivitis - Product Description
Diagnostic Assay - Polimyositis - Product Status
Diagnostic Assay - Polimyositis - Product Description
Diagnostic Assay - Sjogren Syndrome - Product Status
Diagnostic Assay - Sjogren Syndrome - Product Description
Diagnostic Assay - Systemic Lupus Erythematosus - Product Status
Diagnostic Assay - Systemic Lupus Erythematosus - Product Description
Diagnostic Assay - Systemic Sclerosis - Product Status
Diagnostic Assay - Systemic Sclerosis - Product Description
NoToPharm s.r.l., Key Employees
List of Figures
NoToPharm s.r.l. Pipeline Products by Equipment Type
NoToPharm s.r.l. Pipeline Products by Development Stage
NoToPharm s.r.l. Pipeline Products by Therapy Area
Companies Mentioned
Nerviano Medical Sciences S.r.l.
Target Heart S.r.l.
APAvadis Biotechnologies Srl
Confarma S.p.A.
Target Heart S.r.l.
APAvadis Biotechnologies Srl
Confarma S.p.A.
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1945445
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Printed Wednesday, June 19, 2013
7:19:01 AM
7:19:01 AM
Fax order form
To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
Product name
NoToPharm s.r.l. - Product Pipeline Analysis
Web Address
http://www.researchandmarkets.com/reports/1945445
Office Code
OC8DIQQMQSOUQR
Report Formats
Please enter the quantity of the report format you require.
| Format | Quantity | Price |
|---|---|---|
| Electronic (PDF) - Single User |
|
EUR 574 |
| Electronic (PDF) - Enterprisewide |
|
EUR 1,721 |
| Electronic (PDF) - Site License |
|
EUR 1,147 |
Contact information
Please enter all the information below in block capitals.
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
Mrs
Dr
Miss
Ms
Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Page 2 of 2
Printed Wednesday, June 19, 2013
7:19:01 AM
7:19:01 AM
Payment information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
Pay by Check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Pay by Wire Transfer:
Please transfer funds to:
Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp